RITZ Venture Capital
Ritz Venture Capital, established in 2020 and based in Singapore, focuses on investing in early-stage technology companies. The firm aims to support STEM talents and foster innovation for a sustainable future. Its investment strategy encompasses various sectors, including food, healthcare, mobility, and digitalization, reflecting a commitment to nurturing advancements that can contribute to long-term societal benefits.
UNIGRID develops sustainable and affordable sodium-based batteries using abundant materials. They aim to put a battery into every home, the grid, and other distributed energy storage applications. They use dense Na-alloy and a non-flammable electrolyte, which led to high energy density and improved safety.
Knorex
Venture Round in 2023
Knorex, founded in 2009, is a B2B technology company specializing in programmatic advertising solutions aimed at simplifying digital marketing for businesses. Its flagship product, Knorex XPO, is an AI-driven advertising management and execution platform that integrates various digital advertising channels, including social media, search, video, audio, display, and digital out-of-home, into a single interface. This platform leverages machine learning and artificial intelligence to automate and optimize marketing campaigns, allowing advertisers to deliver personalized messages to their target audiences effectively. Operating primarily in the US and Asia-Pacific regions, Knorex focuses on enabling marketers to streamline their advertising processes and enhance business growth.
ACM Biolabs
Venture Round in 2022
ACM Biolabs is a biotechnology company based in Singapore, established in 2013, that specializes in developing innovative vaccines and antibodies utilizing proprietary artificial cell membrane (ACM) technology. This technology allows for the incorporation of functional, folded membrane proteins into artificial cell membranes, ensuring their stability and enhancing the immune response. ACM Biolabs focuses on creating both prophylactic and therapeutic vaccines targeting infectious diseases and personalized cancer treatment. The efficacy of their products has been demonstrated through both injected and oral dosages with synthesized membrane proteins, contributing to a growing pipeline of vaccine and antibody candidates for medical researchers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.